News

Minister Harris asks HPRA for expert advice on medical cannabis

GW Pharmaceuticals reveals second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome.

Epilepsy Ireland is delighted to announce that a new research grant has been awarded to Prof David Henshall at the Royal College of Surgeons in Ireland.

#iseebeyond increases awareness of hidden disability within four months of campaign launch

Seizures while sleeping appear to interrupt memory consolidation, according to a study published in Clinical Neurophysiology.

Canadian researchers at Western University in London, Ontario, have made a significant discovery which could assist in the long term research into epilepsy.

Professor David Henshall and colleagues from RCSI have published new findings identifying a potential disease-modifying drug for epilepsy. Currently, no epilepsy drug offers "disease modifying" effects, meaning that if a patient stops taking the drug their seizures will return.

New UK guidelines produced by the Royal College of Obstetricians and Gynaecologists, recommend women seek advice well before pregnancy on their care.

Medtronic plc, a medical device company based in Dublin, announced on Friday that the US Food and Drug Administration (FDA) has approved the testing of its Visualase(TM) laser ablation system in a clinical trial.

Sleep and rest are important for everyone, without it the risk of a range of health issues, including heart disease, stroke, depression, diabetes, hypertension, and cancer rise.